Results 141 to 150 of about 26,067 (389)

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng   +3 more
wiley   +1 more source

Benzodiazepines : benefits versus risks [PDF]

open access: yes, 2007
Benzodiazepines act on the central nervous system and can be prescribed for various medical conditions. They are usually classified by their duration of action.
West, Lorna Marie
core  

Dreaming in patients with epilepsy: a cross‐sectional cohort study

open access: yesJournal of Sleep Research, EarlyView.
Dream recall frequency in patients with epilepsy is modulated by determinants shared with healthy subjects (age, nocturnal awakenings, role of the parieto‐occipital region) and by epilepsy‐related factors (seizure frequency, epileptic focus location).
Maïlis Charpentier‐Hélary   +11 more
wiley   +1 more source

The Association between General Anesthesia and New Postoperative Uses of Sedative–Hypnotics: A Nationwide Matched Cohort Study [PDF]

open access: gold, 2022
Chen-Yu Tai   +11 more
openalex   +1 more source

A randomised crossover trial of daridorexant for the treatment of chronic insomnia and nocturia

open access: yesJournal of Sleep Research, EarlyView.
Summary This double‐blind, placebo‐controlled, two‐way crossover trial evaluated the efficacy and safety of daridorexant in patients with chronic insomnia and comorbid nocturia. In total, 60 patients aged ≥55 years with insomnia complaints for ≥3 months, Insomnia Severity Index (ISI) ≥13 and ≥3 voids/night for ≥1 month were randomised (1:1) to ...
Katharina Lederer   +9 more
wiley   +1 more source

Rusmidler i Norge 2009 [PDF]

open access: yes, 2009
Rusmidler i Norge inneholder oppdaterte tabeller om forbruk, økonomi, kriminalitet, skadevirkninger og behandling knyttet både til alkohol-, narkotika-, legemiddel- og tobakksbruk.
Bryhni, Anders   +5 more
core  

Home - About - Disclaimer - Privacy